Cary Street Partners’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Cary Street Partners's STE Position: Q2 2026 in Review
Cary Street Partners reduced its Steris (STE) stake by 4.8% in Q2 2026, selling an estimated $1.5K and leaving 140 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.
Cary Street Partners first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $80.2K in Q4 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Cary Street Partners held 140 shares of Steris worth $29.5K as of Q2 2026.
- Cary Street Partners sold 7 Steris shares in Q2 2026, an estimated $1.5K.
- Steris made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #1058 holding.
- Cary Street Partners first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
- Cary Street Partners's Steris position peaked at $80.2K in Q4 2024.
- 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.